Transgender Health (Grin) Flashcards

1
Q

Definition of Gender Identity

A

one’s internal sense of being male, female, neither, both or another gender(s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of Gender Expression

A

physical manifestation of one’s gender identity through clothing, hairstyle, voice, body shape; does NOT tell you about sexual orientation or gender identity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transgender female/ trans-feminine individual

A

assigned male at birth, gender identity is female/feminine spectrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Transgender male/trans-masculine individual

A

assigned female at birth, gender identity is male/masculine spectrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 3 important roles as a physician treating transgender population?

A
  1. Understand basic aspects of transgender health
  2. Provide affirming, respectful care to all patients
  3. Help make health care a safe space for all patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Definition of gender incongruence

A

sex assigned at birth does not align with gender identity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Definition of gender dysphoria

A

clinically significant distress or impairment related to incongruence between sex assigned at birth and gender identity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the goal of gender-affirming hormone therapy?

A

to allow acquisition of secondary characteristics more aligned with the individuals gender identity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 criteria for initiating hormone therapy?

A
  1. marked and sustained gender incongruence
  2. capacity to consent for treatment
  3. mental health and physical conditions that could have negatively impact outcome of treatment have been assessed
  4. Understands effects of hormone therapy on reproduction, and have explored fertility preservation options
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is a formal mental health evaluation (ie psychiatry evaluation) required prior to initiating hormone therapy?

A

NO. it is not required prior to initiating treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is masculinizing hormone therapy not given orally?

A

Testosterone; only delivered via injection to topically; not given orally due to hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Masculinizing hormone therapy effects

A

facial/body hair growth (onset 3-6 mo)
Scalp hair loss (onset >12 mo)
Clitoral enlargement (onset 3-6 mo)
Deepened voice (onset 3-12 mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risks of masculinizing hormone therapy

A

Testosterone; polycythemia/erythrocytosis; monitor CBC in these patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Feminizing hormone therapy

A

Estradiol and androgen blocker (spironolactone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Feminizing hormone therapy effects

A

breast growth (onset 3-6 mo)
decreased testicular volume (onset 3-6 mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Feminizing hormone therapy risks

A

Venous thromboembolism (VTE); risk is higher in smokers

17
Q

Why give an androgen blocker?

A

maximize blockage of testosterone while avoiding supraphysiologic estradiol usage; spironolactone commonly used; risk for hyperkalemia

18
Q

Puberty suppressing agents

A

GnRH analogues; “pause” puberty; delay secondary characteristics; prevent future gender affirming surgeries

19
Q

Fertility considerations of gender-affirming hormone therapy

A

may reduce fertility; options on preservation before starting (sperm banking and egg cryopreservation)

20
Q

Does hormone therapy act as a form of contraception?

A

No. these patients should be offered contraception options of the could produce a pregnancy and do not want to become pregnant

21
Q

Cancer screenings in trans-masculine patients

A

Cervical cancer screening - Pap test starting at 21 yrs
Breast cancer screening - mammogram starting at 50 yrs

22
Q

Cancer screenings for trans-feminine patients

A

Breast cancer screening - mammogram if exposed to feminizing hormones >5 yrs; if not then starting at 50 yrs
Prostate cancer screening - PSA starting at 55 yrs

23
Q

What are two things that intake forms should include?

A
  1. ask separately about sex assigned at birth and gender identity
  2. offer multiple options for gender identity